Xianliang Hou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xianliang Hou has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Guangyu Wang
Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China
4 shared publicationsJunning Zhang
Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China
3 shared publicationsXueli Yang
Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China
3 shared publicationsChune Mo
Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China
2 shared publications- Minglin Ou
Laboratory Center, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, China
2 shared publications Zhenyu Liu
Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, China
2 shared publications
Latest Publications
- 27 July 2023
- Published by Elsevier in Immunobiology
- Vol. 228 (5) , 152722
Metabolomic and proteomic analyses of primary Sjogren’s syndrome
- 27 July 2023
- Published by Elsevier in Immunobiology
- Vol. 228 (5) , 152722
Metabolomic and proteomic analyses of primary Sjogren’s syndrome
- 7 November 2022
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
- Vol. 41 (11) , 2216-2223
Characterisation of T and B cell receptor repertoire in patients with systemic lupus erythematosus
Full Papers; Authors: X. Hou, W. Wei, J. Zhang, Z. Liu, G. Wang, X. Yang, Y. Dai
- 7 November 2022
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology
- Vol. 41 (11) , 2216-2223
Characterisation of T and B cell receptor repertoire in patients with systemic lupus erythematosus
Full Papers; Authors: X. Hou, W. Wei, J. Zhang, Z. Liu, G. Wang, X. Yang, Y. Dai
- 13 October 2022
- Published by Elsevier in Clinical Immunology
- Vol. 245, 109162
Comprehensive analysis of B and T cell receptor repertoire in patients after kidney transplantation by high-throughput sequencing
- 13 October 2022
- Published by Elsevier in Clinical Immunology
- Vol. 245, 109162
Comprehensive analysis of B and T cell receptor repertoire in patients after kidney transplantation by high-throughput sequencing
- 14 May 2022
- Published by Springer Nature in Genes & Genomics
- Vol. 44 (7) , 813-822
Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stage
Background The current pandemic of coronavirus disease 2019 (COVID-19), transmitted person-to-person by the severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2), poses a threat to global public health. Objective In this study, we performed the comprehensive analysis of the T cell receptor (TCR) repertoire may contribute to a more in-depth understanding of the pathogenesis of COVID-19. Methods A comprehensive immunological analysis was performed to explore the features of the TCR repertoire and identified TCR sequences correlated with SARS-CoV-2 viral antigens. Results we analyzed the COVID-19 patients’ TCR repertoires in peripheral blood mononuclear cells (PBMC) which obtained before (baseline), during (acute), and after rehabilitation (convalescent) by ImmunoSEQ-technology, and found that repertoire features of TCRβ-chain (TCRβ) complementary-determining region 3 (CDR3) in COVID-19 patients were remarkable difference, including decreased TCR diversity, abnormal CDR3 length, difference of TRBV/J gene usage and higher TCR sequence overlap. Besides, we identified some COVID-19 disease-associated TCRβ clones, and the abundance of them changed with the progression of the disease. Importantly, these disease-associated TCRβ clones could be used to distinguish COVID-19 patients from healthy controls with high accuracy. Conclusions We provide a clear understanding of the TCR repertoire of COVID-19 patients, which lays the foundation for better diagnosis and treatment of COVID-19 patients.
- 14 May 2022
- Published by Springer Nature in Genes & Genomics
- Vol. 44 (7) , 813-822
Comprehensive analysis of TCR repertoire of COVID-19 patients in different infected stage
Background The current pandemic of coronavirus disease 2019 (COVID-19), transmitted person-to-person by the severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2), poses a threat to global public health. Objective In this study, we performed the comprehensive analysis of the T cell receptor (TCR) repertoire may contribute to a more in-depth understanding of the pathogenesis of COVID-19. Methods A comprehensive immunological analysis was performed to explore the features of the TCR repertoire and identified TCR sequences correlated with SARS-CoV-2 viral antigens. Results we analyzed the COVID-19 patients’ TCR repertoires in peripheral blood mononuclear cells (PBMC) which obtained before (baseline), during (acute), and after rehabilitation (convalescent) by ImmunoSEQ-technology, and found that repertoire features of TCRβ-chain (TCRβ) complementary-determining region 3 (CDR3) in COVID-19 patients were remarkable difference, including decreased TCR diversity, abnormal CDR3 length, difference of TRBV/J gene usage and higher TCR sequence overlap. Besides, we identified some COVID-19 disease-associated TCRβ clones, and the abundance of them changed with the progression of the disease. Importantly, these disease-associated TCRβ clones could be used to distinguish COVID-19 patients from healthy controls with high accuracy. Conclusions We provide a clear understanding of the TCR repertoire of COVID-19 patients, which lays the foundation for better diagnosis and treatment of COVID-19 patients.